Supreme Pharmaceuticals Inc. Changes Name to The Supreme Cannabis Company, Inc. and Announces Conversion of Approximately $17.4 Million Aggregate Principal Amount of 10% Unsecured Convertible Debentures Due 2019
Precious Metals & Critical Minerals Virtual Investor Conference Presentations Now Available for On-Demand Viewing
Precious Metals & Critical Minerals Virtual Investor Conference Presentations Now Available for On-Demand Viewing
Precious Metals & Critical Minerals Virtual Investor Conference Presentations Now Available for On-Demand Viewing